FDA’s removal of Ozempic, Wegovy from drug shortage list upheld

A national justice connected Wednesday ruled that the Food and Drug Administration’s (FDA) determination to region fashionable GLP-1s from its cause shortage list, ending the merchantability of compounded versions of the drugs, was lawful and that the bureau acted correctly. U.S. District Court Judge Mark Pittman recovered that the Outsourcing Facilities Association (OFA), an organization…